EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer

BACKGROUND: EGFR/c-Met activation/amplification and co-expression, mTOR upregulation/activation, and Akt/Wnt signaling upregulation have been individually associated with more aggressive disease and characterized as potential prognostic markers for lung cancer patients. METHODS: Tumors obtained from...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Ther Adv Med Oncol
Κύριοι συγγραφείς: Crees, Zachary D, Shearrow, Caleb, Lin, Leo, Girard, Jennifer, Arasi, Kavin, Bhoraskar, Aayush, Berei, Joseph, Eckburg, Adam, Anderson, Austin D., Garcia, Christian, Munger, Ariana, Palani, Sunil, Smith, Thomas J, Sreenivassappa, Shylendra B, Vitali, Connie, David, Odile, Puri, Neelu
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: SAGE Publications 2020
Θέματα:
Advances in Treatment of Lung Cancer Patients with Targetable Mutations
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7493230/
https://ncbi.nlm.nih.gov/pubmed/32973931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920953731
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια